951.02KMarket Cap-28P/E (TTM)
0.5045High0.4326Low896.19KVolume0.5045Open0.5050Pre Close411.93KTurnover46.34%Turnover RatioLossP/E (Static)2.15MShares8.655052wk High0.95P/B854.93KFloat Cap0.432652wk Low--Dividend TTM1.93MShs Float2141994.0840Historical High--Div YieldTTM14.24%Amplitude0.4326Historical Low0.4590Avg Price1Lot Size
Cyclacel Pharmaceuticals Stock Forum
Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule
BERKELEY HEIGHTS, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that initial safety and efficacy data from twelve patients with advanced solid tumors enrolled i...
📊⚡️📊
No comment yet